Lead sponsor
General Committee of Teaching Hospitals and Institutes, Egypt
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
1
Trials led
0
Ongoing
60
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
1
Trials by status
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.BMI ≥35not applicableUnknown60